Ers cyflwyno’r gwaharddiad, mae cynhyrchion meddyginiaethol sy’n deillio o blasma wedi gorfod cael eu mewnforio, yn bennaf o’r Unol Daleithiau ar hyn o bryd.
Since the introduction of the ban, plasma-derived medicinal products have had to be imported, with the main source at present being the USA.